SCHEMBL2675873

SCHEMBL2675873

O=C(O)c1c(CN2CCCN(c3ncccn3)CC2)n(-c2ccccc2)c(=O)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LMNA P02545 3/20 0.45
HTR7 P34969 1/20 0.42
DRD4 P21917 2/20 0.42
MDM2 Q00987 1/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
HTR1A P08908 1/20 0.42
TSHR P16473 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 2/20 0.40
HTT P42858 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676797 0.96 ALDH1A1 (0.50) ALDH1A1KDM4ENPSR1LMNAHTR7
SCHEMBL2676392 0.87 MAPK1 (0.45) ALDH1A1KDM4ENPSR1LMNATSHR
SCHEMBL1718050 0.86 KDM4E (0.49) ALDH1A1KDM4ENPSR1LMNAHTR7
SCHEMBL2675569 0.85 ALDH1A1 (0.46) ALDH1A1KDM4ENPSR1LMNATSHR
SCHEMBL2677517 0.84 ALDH1A1 (0.47) ALDH1A1KDM4ENPSR1LMNATSHR
SCHEMBL2676750 0.84 ALDH1A1 (0.47) ALDH1A1KDM4ENPSR1LMNATSHR
SCHEMBL1718824 0.84 TACR3 (0.47)
SCHEMBL2675296 0.83 KDM4E (0.50) ALDH1A1KDM4ENPSR1LMNATSHR
SCHEMBL2677561 0.83 ALDH1A1 (0.42) ALDH1A1KDM4ENPSR1LMNAHTR7
SCHEMBL2676745 0.82 NPSR1 (0.39) ALDH1A1KDM4ENPSR1LMNAHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173639-B2 Isoquinolinone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-05-08 US claimed
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2009-06-04 US claimed
US-8173639-B2 Isoquinolinone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-05-08 US disclosed
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS KCNQ3, KCNK3, GRIK3 ALDH1A1 2304/4885KDM4E 3176/4885NPSR1 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.